Skip to content

Blog

Moneycontrol Pro Panorama | A sobering outlook for IT, but TCS can just sail through

Moneycontrol Pro Panorama | A sobering outlook for IT, but TCS can just sail through

In today’s edition of Moneycontrol Pro Panorama: Budget boost to Indian firms, trade diplomacy tweak to improve India-US ties, India#39;s steel demand grows, Xi Jinping plans to reset China’s economy, and more Read More ​ In today’s edition of Moneycontrol Pro… Read More »Moneycontrol Pro Panorama | A sobering outlook for IT, but TCS can just sail through

Moneycontrol Pro Panorama | A sobering outlook for IT, but TCS can just sail through

Moneycontrol Pro Panorama | A sobering outlook for IT, but TCS can just sail through

In today’s edition of Moneycontrol Pro Panorama: Budget 2023 can boost Indian firms, tweak trade diplomacy to improve India-US ties, does strong dollar help technology stocks, media brand—the message or messenger, and more Read More ​ In today’s edition of Moneycontrol… Read More »Moneycontrol Pro Panorama | A sobering outlook for IT, but TCS can just sail through

Taking Stock | Market in reverse gear; Sensex tanks 631 points, Nifty below 18,000

Taking Stock | Market in reverse gear; Sensex tanks 631 points, Nifty below 18,000

Adani Enterprises, Bharti Airtel, Eicher Motors, Adani Ports and SBI were among the top Nifty losers. The biggest gainers included Tata Motors, Hindalco Industries, Apollo Hospitals, Power Grid Corp and Divis Labs Read More ​ Adani Enterprises, Bharti Airtel, Eicher Motors,… Read More »Taking Stock | Market in reverse gear; Sensex tanks 631 points, Nifty below 18,000

Glenmark launches generic version of diuretic with $16.5-million market

Glenmark launches generic version of diuretic with $16.5-million market

Glenmark Pharmaceuticals will launch single-dose and multi-dose vials of Bumetanide injection USP, the company has said Read More ​ Glenmark Pharmaceuticals will launch single-dose and multi-dose vials of Bumetanide injection USP, the company has said Glenmark Pharmaceuticals will launch single-dose and… Read More »Glenmark launches generic version of diuretic with $16.5-million market

en_USEnglish